The law was the crowning achievement of a multifaceted campaign by the drug industry to weaken aggressive DEA enforcement efforts against drug distribution companies that were supplying corrupt doctors and pharmacists who peddled narcotics to the black market. The industry worked behind the scenes with lobbyists and key members of Congress, pouring more than a million dollars into their election campaigns.

The chief advocate of the law that hobbled the DEA was Rep. Tom Marino,

a Pennsylvania Republican who is now President Trump’s nominee to become the nation’s next drug czar. Marino spent years trying to move the law through Congress. It passed after Sen. Orrin G. Hatch

(R-Utah) negotiated a final version with the DEA.

(http://www.autoadmit.com/thread.php?thread_id=3765558&forum_id=2#34453231)

(I think)

(http://www.autoadmit.com/thread.php?thread_id=3765558&forum_id=2#34453239)

(http://www.autoadmit.com/thread.php?thread_id=3765558&forum_id=2#34453249)

The news came after a bombshell report from the Washington Post and 60 Minutes that looked at Marino’s involvement in a law passed in 2016: the so-called Ensuring Patient Access and Effective Drug Enforcement Act.

The law made it very difficult, if not impossible, for the US Drug Enforcement Administration (DEA) to stop suspicious shipments of opioid painkillers by drug distributors, according to an upcoming law review article by DEA Chief Administrative Law Judge John Mulrooney.

(http://www.autoadmit.com/thread.php?thread_id=3765558&forum_id=2#34493801)